A Study to Evaluate the PK, Safety and Tolerability of HCP1803.
Clinical trial NCT05723549 · COMPLETED
Trial details
- NCT number
- NCT05723549
- Sponsor
- Hanmi Pharmaceutical Company Limited
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-02-02
- Primary completion
- 2023-03-20
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.